scispace - formally typeset
H

Harlan M. Krumholz

Researcher at Yale University

Publications -  1966
Citations -  177853

Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.

Papers
More filters
Journal ArticleDOI

Database Conference Washington D.C.: Do existing databases answer clinical questions about geriatric cardiovascular disease and stroke?

TL;DR: The goal of this conference was to convene the principal investigators of key databases, and others in the field of geriatric cardiology, to address questions relating to the safety and effectiveness of treatment interventions for several cardiovascular conditions in the elderly.
Journal ArticleDOI

COCATS 4 Task Force 15: Training in Cardiovascular Research and Scholarly Activity

TL;DR: The writing committee was selected to represent the American College of Cardiology and included a cardiovascular training program director, several active cardiovascular scientists and research methodology.
Journal Article

Readmission rates, 30 days and 365 days postdischarge, among the 20 most frequent DRG groups, Medicare inpatients age 65 or older in Connecticut hospitals, fiscal years 1991, 1992, and 1993.

TL;DR: With the exception of the DRG category representing cancer (all types), within which there was a significant decrease in readmission rates over the three years examined, the crude readmissions rates for theDRG categories were found to be stable over theThree-year study period.
Journal ArticleDOI

Improvements in the distribution of hospital performance for the care of patients with acute myocardial infarction, heart failure, and pneumonia, 2006-2011.

TL;DR: From 2006 to 2011, not only did the median performance improve but the distribution of performance narrowed, and focus needs to shift away from processes measures to new measures of quality.
Journal ArticleDOI

Beta-Blockers after Myocardial Infarction — For Few Patients, or Many?

TL;DR: Sir James W. Black developed propranolol, which the Nobel Committee in 1988 called “the greatest breakthrough when it comes to pharmaceuticals against heart illness since the discovery of digitalis 200 years ago", by showing that beta-blockers improve survival after myocardial infarction.